Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era

Gisselbrecht, Christian; Glaß, Bertram; Mounier, Nicolas; Gill, Devinder; C. Linch, David; Trněný, Marek; Bosly, André; Ketterer, Nicolas; Shpilberg, Ofer; Hagberg, Hans; Ma, Dávid; Brière, Josette; H. Moskowitz, Craig; Schmitz, Norbert

doi:10.1200/jco.2010.28.1618

Public

Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era

Published in Journal of Clinical Oncology • Jul 26, 2010

Authors:

Christian Gisselbrecht

Bertram Glaß

Nicolas Mounier

Abstract

PURPOSE: Salvage chemotherapy followed by high-dose therapy and autologous stem-cell transplantation (ASCT) is the standard treatment for relapsed diffuse large B-cell lymphoma (DLBCL). Salvage regimens have never been compared; their efficacy in the rituximab era is unknown. PATIENTS AND METHODS: P...

Subject

Medicine

Rituximab

Internal medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!